Malaria is a serious tropical disease spread by mosquitoes. If it isn’t diagnosed and treated promptly, it can be fatal.
A single mosquito bite is all it takes for someone to become infected.
Symptoms of malaria
It’s important to be aware of the symptoms of malaria if you’re travelling to areas where there’s a high risk of the disease. Symptoms include:
a high temperature (fever) sweats and chills headaches vomiting muscle pains diarrhoea Symptoms usually appear between 7 and 18 days after becoming infected, but in some cases the symptoms may not appear for up to a year, or occasionally even longer.
When to seek medical attention
Seek medical help immediately if you develop symptoms of malaria during or after a visit to an area where the disease is found.
Malaria risk areas
Malaria is found in more than 100 countries, mainly in tropical regions of the world, including:
large areas of Africa and Asia Central and South America Haiti and the Dominican Republic parts of the Middle East some Pacific islands
Thehas more information about the risk of malaria in specific countries.
Preventing malaria
Many cases of malaria can be avoided. An easy way to remember is the ABCD approach to prevention:
Awareness of risk – find out whether you’re at risk of getting malaria before travelling Bite prevention – avoid mosquito bites by using insect repellent, covering your arms and legs, and using an insecticide-treated mosquito net Check whether you need to take malaria prevention tablets – if you do, make sure you take the right antimalarial tablets at the right dose, and finish the course Diagnosis – seek immediate medical advice if you develop malaria symptoms, as long as up to a year after you return from travelling
Side effects
Like all medicines, doxycycline can cause side effects, although not everyone gets them.
Common side effects These common side effects happen in around 1 in 10 people. Keep taking the medicine, but talk to your doctor or pharmacist if these side effects bother you or don’t go away:
a headache feeling sick or vomiting being sensitive to sunlight Serious side effects Serious side effects are rare and happen in less than 1 in 1,000 people.
Call a doctor straight away if you get:
Bruising or bleeding you can’t explain (including nosebleeds), a sore throat, a high temperature (38C or above) and you feel tired or generally unwell – these can be signs of blood problems.
Severe diarrhoea (perhaps with stomach cramps) that contains blood or mucus, or lasts longer than 4 days ringing or buzzing in your ears
Serious skin reactions or rashes, including irregular, round red patches, peeling, blisters, skin ulcers, or swelling of the skin that looks like burns – these could be signs of a rare reaction to the medicine called Stevens-Johnson Syndrome
Yellow skin or the whites of your eyes go yellow – this could be a sign of liver problems joint or muscle pain that has started since you began taking doxycycline
Headache, vomiting and problems with your vision – these could be signs of pressure around your brain (intracranial hypertension)
A fingernail coming away from its base – this could be a reaction to sunlight called photo-onycholysis
A sore or swollen mouth, lips or tongue
Severe pain in your tummy, with or without bloody diarrhoea, feeling sick and being sick – these can be signs of pancreatitis difficulty or pain when you swallow, a sore throat, acid reflux, a smaller appetite or chest pain which gets worse when you eat – these could be signs of an inflamed food pipe (oesophagitis) or oesophageal ulcer
Serious allergic reactions
Allergic reactions to doxycycline are common and occur in more than 1 in 100 people.
These are not all the side effects of doxycycline.
You can report any suspected side effect to the UK.
Like all medicines, doxycycline can cause side effects, but some 1% doxycycline can cause more serious side effects than others.
In a world where a new wave of antibiotic resistance emerges, the treatment of malaria is a key issue. This new era of drug discovery opens a world of possibilities, paving the way for more effective, more affordable treatment.
At the moment, however, new research emerges that will transform the world of malaria, and the world of antibiotic resistance.
The new research, a phase I clinical trial for malaria prevention, will use a combination of chloroquine (a tetracycline antibiotic) and a novel antimalarial agent, doxycycline.
The researchers in a phase II clinical trial are studying the efficacy of the combination in clinical trials for malaria, to assess the safety and tolerability of the drug, and the role of doxycycline as an active drug in malaria prevention.
The research will focus on dosing regimens in combination with chloroquine in clinical trials.
The trial will be carried out at an academic laboratory, and will run for 18 months.
The drug is not approved for the prevention of malaria. However, it has been tested for its ability to prevent malaria in children, and in adults, who are at a high risk for contracting the disease.
It has also been tested for the effectiveness of treating malaria.
The drug, which is taken by mouth, has been evaluated for efficacy and safety in adults and children under the age of six years.
The study is based on the results of a phase I clinical trial for malaria prevention, the first ever in the world.
This study is being carried out with the aim of increasing the number of clinical trials that are in the pipeline.
As the first phase II clinical trial to be carried out, the researchers will carry out a series of follow-up trials to evaluate the efficacy and safety of doxycycline in combination with chloroquine.
The trial will run for 12 weeks in the United States, and the results of that trial will be published in the Journal of Clinical Infection.
In this trial, 100 people will be randomized to receive either 500 mg of doxycycline or 200 mg of chloroquine. Each patient will receive a blood test to measure their blood levels of the antibiotic at the end of the trial.
The results of the blood tests will be reviewed for a period of 2 weeks in a phase II clinical trial. The data will be analysed in terms of the effectiveness of the treatment and side effects.
The trial is expected to be completed by the end of the year.
The researchers hope to take the trial on the track to achieve the most accurate results and to achieve the most successful outcome.
The study is in the early stages of the scientific development of malaria, and is being carried out with the aim of increasing the number of clinical trials that are in the pipeline.
Photography: © The WelsherTheThe Welsher Institute of Medicine and Health Sciences, University of Liverpool, will carry out an observational phase I study for malaria prevention to assess the efficacy of the combination of doxycycline and chloroquine in the treatment of this disease.
The trial is being carried out with the aim of increasing the number of clinical trials that are in the pipeline.
The study will run for 18 months in the United States, and the results of that trial will be published in the Journal of Clinical Infection.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$23.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep the package with the pack. If you have any questions, consult with your pharmacist or contact customer service.Warnings/Advice About Devicerington P. R. L. (Healthylife)This is not a complete guide. Beware of unprotected or unauthorized use. If you are allergic to any ingredient in this product, you should stop using the product immediately and consult your doctor. If you are receiving medication through a postal service, please ensure you read our product labeling for the correct dosage and packaging. Beware of accidental overdose. If medically intact, contact a doctor immediately. Do not consume alcohol as it may cause health problems. Consuming medication while taking it may increase the risk of side effects, such as nausea, vomiting, stomach pain or diarrhea. If you are taking other medicines, always inform your doctor before starting them. It is important to only take medication for as long as it is prescribed. Stopping abruptly may cause harm. Medicines that have been used for more than 3 months may have a higher chance of side effects. Medicines that have been stopped suddenly or have been used for more than 1 year may cause a medical emergency. Medicines that have been stopped for more than a year may have a higher chance of side effects. Medicines that have been stopped suddenly or have been used for more than 1 year may cause a physical harm. Stopping the medication suddenly can cause health problems. Stopping the medication suddenly may cause health problems. Medicines that have been stopped for more than a year may cause a physical harm.
Product Information
Doxycycline Capsules are a highly effective antibiotic used to treat a wide range of bacterial infections. They are available in different formulations as:
Doxycycline Capsules are usually taken orally and can be mixed with food or water for better absorption.
It is important to follow the doctor's instructions when taking these capsules. They should be taken at the same time each day to maintain the best results.
Recommended Dosage
For the treatment of urinary tract infections, Doxycycline Capsules are recommended to be taken twice a day for the first two days of the infection. It is important to take this medicine with a full glass of water at the same time every day to avoid any side effects.
For the prevention of malaria in certain regions, it is recommended to take Doxycycline Capsules with food or milk to prevent stomach irritation.
It is not recommended to take this medication with dairy products or calcium-fortified juices, as they may reduce its effectiveness.
Dosage Instructions
Salt Composition in both
Salt Composition
Doxycycline 100mg(same for both)
You Searched
Strip of 10 capsules
We only sell the best substitute from top brands
Our Recommendation
Doxypen 100mg Capsule 10s
2,672+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
ordinaries.rhubionmarketing.comWe provide detailed information on various markets and payment options available to our customers.
Wagner T, Whelton G, Loeber J, et al. Inhibition of expression of the tetracycline-responsive promoter in the human lung cancer cell line, HT-29. J Clin Microbiol. 2006;24:3270–4. Published online: January 14, 2016.
Bourcher C, Gossman N, Fruhe L, et al. Inhibition of gene expression in human lung cancer cells by doxycycline. Mol Res Microbiol. 2010;18:1–14. Published online: January 23, 2016.
Gossman N, Gossman G, Koppelkraad A, et al. Inhibition of gene expression by doxycycline in human lung cancer cells. 2010;18:2–5.
Boucher C, Gossman N, Gossman G, et al. Inhibition of expression of the tetracycline-responsive promoter in human lung cancer cells by doxycycline. 2010;18:5–9.
Inhibition of expression of the tetracycline-responsive promoter in human lung cancer cells. 2010;18:8–17.
2010;18:12–16.
Wagner T, Koppelkraad A, Gossman N, et al.
2010;18:17–19.
2010;18:6–8.
2010;18:11–15.
2010;18:16–23.
2010;18:20–24.
Stade de France Pharmacy